Cardio Diagnostics Holdings, Inc. (CDIO)
NASDAQ: CDIO · Real-Time Price · USD
1.830
-0.140 (-7.11%)
At close: May 5, 2026, 4:00 PM EDT
1.870
+0.040 (2.19%)
Pre-market: May 6, 2026, 6:19 AM EDT
CDIO Market Cap
CDIO has a market cap or net worth of $5.42 million as of May 6, 2026. Its market cap has decreased by -73.36% in one year.
Market Cap
5.42M
Enterprise Value
1.00M
1-Year Change
-73.36%
Ranking
Category
Stock Price
$1.83
Market Cap Chart
Since July 26, 2022, CDIO's market cap has decreased from $368.96M to $5.42M, a decrease of -98.53%. That is a compound annual growth rate of -67.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 4, 2026 | 5.83M | 17.81% |
| Dec 31, 2025 | 4.95M | -86.66% |
| Dec 31, 2024 | 37.08M | -27.41% |
| Dec 29, 2023 | 51.09M | 406.54% |
| Dec 30, 2022 | 10.09M | -97.27% |
| Jul 26, 2022 | 368.96M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Can-Fite BioPharma | 6.53M |
| Aptevo Therapeutics | 6.44M |
| CNS Pharmaceuticals | 6.36M |
| Purple Biotech | 6.30M |
| BioRestorative Therapies | 6.17M |
| CollPlant Biotechnologies | 6.03M |
| Alaunos Therapeutics | 6.02M |
| BiomX | 5.88M |